Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) had its target price cut by Raymond James from $78.00 to $64.00 in a research note released on Tuesday morning, Benzinga reports. They currently have a strong-buy rating on the stock. A number of other research analysts have also recently issued reports on MIRM. JPMorgan Chase & Co. reissued […]
Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) had its target price lowered by HC Wainwright from $60.00 to $58.00 in a report published on Monday morning, Marketbeat.com reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Mirum Pharmaceuticals’ Q1 2024 earnings at ($0.13) EPS, Q2 2024 earnings at […]
Mirum Pharmaceuticals, Inc (NASDAQ:MIRM) Given Consensus Rating of Buy by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Morgan Stanley assumed coverage on shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) in a research report released on Monday, Marketbeat.com reports. The brokerage issued an overweight rating and a $60.00 price target on the stock. Several other brokerages have also commented on MIRM. HC Wainwright decreased their price target on Mirum Pharmaceuticals from $63.00 […]
Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) had its price target reduced by Raymond James from $84.00 to $77.00 in a report released on Wednesday, Benzinga reports. Raymond James currently has a strong-buy rating on the stock. A number of other research analysts also recently commented on the stock. Robert W. Baird raised their target price […]